Side Effects of Tirzepatide (No Specific Interaction with Glycine)
There is no evidence of specific drug interactions or combined side effects between tirzepatide and glycine supplementation. The side effects you should expect are those of tirzepatide alone, as glycine (when used as an oral supplement) does not appear to interact with this medication.
Primary Side Effects of Tirzepatide
Gastrointestinal Effects (Most Common)
The most frequent side effects are gastrointestinal and occur in a dose-dependent manner 1, 2:
- Nausea: Occurs in approximately 25% of patients, ranging from 10-44% depending on dose 1, 3
- Diarrhea: Affects 7-32% of patients 1, 3
- Vomiting: Seen in 2-25% of patients 1, 3
- Constipation: Occurs in 3-23% of patients 3
These symptoms are most pronounced during dose escalation and many patients develop tolerance over time 1. The 15 mg dose shows the highest incidence at 49% for overall GI adverse events 4.
Serious but Rare Complications
Gallbladder and Biliary Disease: Tirzepatide increases the risk of gallbladder or biliary disease in patients with type 2 diabetes and obesity 1. This is a class effect of GLP-1 receptor agonists and occurs with weight loss from any modality, but appears augmented with these medications 2.
Pancreatitis: While causality has not been definitively established, pancreatitis has been reported in clinical trials 5. Stop the medication immediately if severe abdominal pain with or without nausea/vomiting develops 1.
Metabolic Complications:
- Ketoacidosis has been reported, even in non-diabetic patients 6
- Severe electrolyte disturbances from prolonged vomiting/diarrhea can lead to life-threatening arrhythmias 7
Contraindications and Warnings
Absolute contraindication: Personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia type 2 (MEN 2) 1, 3. This carries a black box warning due to thyroid C-cell tumor risk observed in rodents.
Use with caution in:
- Kidney disease (risk of acute kidney injury, especially with dehydration from GI side effects) 2, 5
- History of pancreatitis (though not an absolute contraindication) 3
Other Notable Effects
- Injection site reactions: Pain and hemorrhage at injection sites 8
- Modest increase in heart rate 2
- Hypoglycemia: Low risk when used alone (≤1%), but increases when combined with insulin or sulfonylureas 4, 9
- Alopecia: Reported in 1-6% of patients 3
- Drug discontinuation: Highest with 15 mg dose at 10% 4
Mitigation Strategies
To minimize gastrointestinal side effects 1, 2:
- Start with the lowest dose (2.5 mg weekly) and titrate slowly monthly
- Eat smaller, more frequent meals
- Stop eating when feeling full
- Avoid high-fat and spicy foods
- Drink plenty of water
- Increase dietary fiber
- Moderate alcohol and carbonated beverages
- Eat slowly
Monitor for dehydration and electrolyte disturbances, particularly in patients experiencing significant vomiting or diarrhea 2, 7.
Regarding Glycine Specifically
The FDA label for glycine irrigation solution 10 describes adverse events related to intravascular absorption during urologic procedures (not oral supplementation), including nausea, salivation, and electrolyte disturbances. These are not relevant to oral glycine supplementation and do not represent a drug interaction with tirzepatide.
There is no documented pharmacokinetic or pharmacodynamic interaction between tirzepatide and oral glycine supplementation in the available evidence. The side effect profile remains that of tirzepatide alone.